| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |